CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma

Bibliographic Details
Main Authors:	Lin, Yan, Zhong, Ying, Guan, Heng, Zhang, Xiaohui, Sun, Qiang
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432011/

Similar Items

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma
by: Iris Rabinovich, et al.
Published: (2018-09-01)

Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas
by: Oliveira-Costa, João Paulo, et al.
Published: (2011)

Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24− breast cancer cells
by: Van Phuc, Pham, et al.
Published: (2011)

Can CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?
by: Wu, Hong, et al.
Published: (2011)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
by: Soave, Danilo Figueiredo, et al.
Published: (2013)

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
by: Bhat-Nakshatri, Poornima, et al.
Published: (2010)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
by: Magalhães, Geórgia Modé, et al.
Published: (2013)

Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma
by: Zheng, Zhousan, et al.
Published: (2014)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
by: Han, Zhengquan, et al.
Published: (2015)

Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
by: Ghebeh, Hazem, et al.
Published: (2013)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
by: Lin, Z., et al.
Published: (2001)

STAT3 mediates resistance of CD44+CD24−/low breast cancer stem cells to tamoxifen in vitro
by: Wang, Xiaoyan, et al.
Published: (2012)

Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?
by: Lee, Jeong Eon, et al.
Published: (2011)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Published: (1996)

The Phenotypic Radiation Resistance of CD44+/CD24−or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
by: Yin, Hong, et al.
Published: (2011)

CD44+/CD24− breast cancer cells exhibit phenotypic reversion in three-dimensional self-assembling peptide RADA16 nanofiber scaffold
by: Mi, Kun, et al.
Published: (2015)

Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44+/CD24−/low Stem Cell Phenotype
by: Gao, Xuefeng, et al.
Published: (2016)

Another Notch in CD44
by: Dove, Alan W.
Published: (2001)

The liberation of CD44
by: Cichy, Joanna, et al.
Published: (2003)

CD44 in rheumatoid arthritis
by: Naor, David, et al.
Published: (2003)

Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
by: Fillmore, Christine, et al.
Published: (2007)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
by: Jaggupilli, Appalaraju, et al.
Published: (2012)

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
by: Sheridan, Carol, et al.
Published: (2006)

Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis
by: Wei, Wei, et al.
Published: (2012)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
by: Lin, Li, et al.
Published: (2013)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong, Ching-Shya, et al.
Published: (2012)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
by: Perrone, Giuseppe, et al.
Published: (2012)

Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice
by: Yan, Wenxing, et al.
Published: (2013)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
by: Cao, Xueyuan, et al.
Published: (2014)

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
by: Cortes-Dericks, Lourdes, et al.
Published: (2014)

'Aging' granular cells in ameloblastoma have a CD44+/Snail+ Phenotype
by: Siar, C.H., et al.
Published: (2017)

CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation
by: Lin, Chien-Hung, et al.
Published: (2013)

Detection of Malignant Cells in Pleural Fluid or Ascites by CD44v8-10/CD44v10 competitive RT-PCR
by: Ahn, Myung-Ju, et al.
Published: (2001)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
by: Sahlberg, Sara Häggblad, et al.
Published: (2014)

CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast
by: ZAINAB BINTI AWANG NGAH
Published: (2006)

Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
by: Zhang, Jianli, et al.
Published: (2014)

c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice
by: Olaku, Vivienne, et al.
Published: (2011)

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
by: Okamoto, Isamu, et al.
Published: (2001)

A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid
Published: (1996)

Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding
Published: (1993)